Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhACE2 in Adult Patients With COVID-19
NCT04287686Withdrawn
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Feb 2020
- Primary completion
- Apr 2020
- Modality
- Peptides, Replacement Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of alunacedase alfa in coronavirus disease 2019 (COVID-19), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Planned start Feb 2020; status: withdrawn.
02
Drugs
alunacedase alfa
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04287686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04287686.